Korean J Occup Environ Med.  2012 Jun;24(2):115-123.

The Relationship of Serum Vitamin D Levels and the Framingham Risk Score among Male Workers in the Manufacturing Sector

• Park SH
• Kim YW
• Chae CH
• Son JS
• Kim CW
• Kim JY
• Kim JH

Abstract

OBJECTIVES
A growing body of evidence states that vitamin D deficiencies may adversely affect cardiovascular disease, however data from Korean workers are lacking. The purpose of this study was to investigate the vitamin D level of the Korean worker and the relationship between vitamin D levels and the Framingham Risk Score.
METHODS
11,448 male workers who visited a university hospital for health screening between March 2010 and August 2011, were enrolled in the study. We measured their of serum vitamin D(25(OH)D) levels and calculated their Framingham Risk Score.
RESULTS
The mean serum vitamin D(25(OH)D) level of the surveyed workers was 13.03+/-6.47 ng/mL. 12.4% of the total workers had adequate vitamin D levels. It was found that the lower the vitamin D level, the higher the risk of cardiovascular disease. The Framingham Risk Score and vitamin D levels were found to be significantly related (OR=1.39, 95% CI 1.14~1.68) through a multivariate logistic regression analysis.
CONCLUSIONS
87.6% of workers possessed inappropriate vitamin D levels. Management for this high risk group in regards to cardiovascular disease should be included in the evaluation and vitamin D levels should be corrected.

Keyword

Vitamin D deficiency; Cardiovascular disease; Risk factors

MeSH Terms

Cardiovascular Diseases
Humans
Logistic Models
Male
Mass Screening
Risk Factors
Vitamin D
Vitamin D Deficiency
Vitamins
Vitamin D
Vitamins

Reference

1. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001. 22(4):477–501.

2. Holick MF. Vitamin D deficiency. N Engl J Med. 2007. 357:266–281.

3. Chen TC, Holick MF. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab. 2003. 14:423–430.

4. Bises G, Kallay E, Weiland T, Wrba F, Wenzl E, Bonner E, Kriwanek S, Obrist P, Cross HS. 25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem. 2004. 52:985–989.

5. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001. 357:1673–1674.

6. Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987. 79(6):1659–1664.

7. Bikle DD. Vitamin D regulation of immune function. Vitam Horm. 2011. 86:1–21.

8. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007. 99(21):1594–1602.

9. Caan B, Neuhouser M, Aragaki A, Lewis CB, Jackson R, LeBoff MS, Margolis KL, Powell L, Uwaifo G, Whitlock E, Wylie-Rosett J, LaCroix A. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007. 167(9):893–902.

10. Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition. 2011. 27(9):868–879.

11. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002. 110(2):229–238.

12. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappe DL, Muhlestein JB. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a genaral healthcare population. Am J Cardiol. 2010. 106(7):963–968.

13. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, MAnson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006. 29(3):650–656.

14. Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens. 2012. 30(2):284–289.

15. Wolden-Kirk H, Overbergh L, Christesen HT, Brusqaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011. 347:106–120.

16. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007. 50(1):69–77.

17. Choi HJ. New insight into the action of vitamin D. Korean J Fam Med. 2011. 32:89–96. (Korean).

18. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007. 167(11):1159–1165.

19. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008. 52(24):1949–1956.

20. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003. 88(2):327–331.

21. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008. 168(12):1340–1349.

22. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997. 30:150–156.

23. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008. 117(4):503–511.

24. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003. 41(1):105–112.

25. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004. 80:1678S–1688S.

26. The top 10 causes of death 2008. World Health Organization. cited 23 October 2011. Available: http://www.who.int/mediacentre/factsheets/fs310/en/.

27. Cause of Death Statistics. Korea National Statistical Office. cited 23 October 2011. Available: http://kosis.kr/abroad/abroad_01List.jsp.

28. Occupational Accidents and Diseases statistics. Korea Occupational Safety and Health Agency. cited 23 October 2011. Available: http://www.kosha.or.kr/bridge?menuId=553.

29. Pasternak RC, Grundy SM, Levy D, Thompson PD. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease. J Am Coll Cardiol. 1996. 27(5):978–990.

30. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002. 106(3):388–391.

31. Kim MB, Park WJ, Jang KH, Lee DK, Chae HJ, Moon JD. Comparison of cardiovascular disease risk assessment tools by using coronary CT angiography. Korean J Occup Environ Med. 2010. 22(2):102–113. (Korean).

32. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011. 31(1):48–54.

33. Moon SJ, Kim JH, Kim SW, Kim SY, Lim SK. Vitamin D status and related biochemical parameters of women in Korea. Korean J Nutr. 1996. 29:758–771. (Korean).

34. Lee MK, Yoon BK, Chung HY, Park HM. The serum vitamin D nutritional status and its relationship with skeletal status in Korean postmenopausal women. Korean J Obstet Gynecol. 2011. 54:241–246. (Korean).

35. Cho SW, Kim SW, Shin CS, Kim SY. The prevalence and the threshold of vitamin D insufficiency in Korea. Korean J Bone Metab. 2007. 14:19–26.

36. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008. 117(6):743–753.

37. Vitamin D. National Institutes of Health. cited 23 October 2011. Available: http://ods.od.nih.gov/factsheets/vitamind/.

38. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006. 81(3):353–373.

39. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1998-2004. Arch Intern Med. 2009. 169(6):626–632.

40. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005. 90(6):3215–3224.

41. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, Ragi-Eis S, Chandler J. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med. 2006. 260(3):245–254.

42. Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, Barrett-Connor E, Shikany JM, Dam T, Cauley JA. Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009. 94(4):1214–1222.

43. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M, Impivaara O, Reunanen A. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009. 170(8):1032–1039.

44. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Korea Centers for Disease Control and Prevention. cited 13 February 2012. Available: http://knhanes.cdc.go.kr.

45. Local climate 30 years average data. Korea Meteorological Administration. cited 13 February 2012. Available : http://www.kma.go.kr/weather/climate/average_30years.jsp.

46. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008. 168(11):1174–1180.

47. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008. 168(12):1340–1349.

48. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991. 83(1):356–362.